Citizens Price To Sales Ratio vs Capex To Revenue Analysis

CZFS Stock

USD 69.39 0.67 0.96%

Citizens Financial financial indicator trend analysis is way more than just evaluating Citizens Financial prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Citizens Financial is a good investment. Please check the relationship between Citizens Financial Price To Sales Ratio and its Capex To Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Citizens Financial Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Price To Sales Ratio vs Capex To Revenue

Price To Sales Ratio vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Citizens Financial Price To Sales Ratio account and Capex To Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Citizens Financial's Price To Sales Ratio and Capex To Revenue is 0.92. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Citizens Financial Services, assuming nothing else is changed. The correlation between historical values of Citizens Financial's Price To Sales Ratio and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Citizens Financial Services are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Price To Sales Ratio i.e., Citizens Financial's Price To Sales Ratio and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

0.92

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Citizens Financial stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Citizens Financial sales, a figure that is much harder to manipulate than other Citizens Financial Services multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Citizens Financial's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Citizens Financial current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Citizens Financial Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Selling General Administrative is likely to gain to about 38.3 M in 2024. Tax Provision is likely to gain to about 5.2 M in 2024

	2021	2022	2023	2024 (projected)
Interest Expense	7.1M	11.2M	46.9M	49.2M
Depreciation And Amortization	1.1M	1.0M	1.5M	1.6M

Interest Expense Depreciation And Amortization

Citizens Financial fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Total Current Liabilities	Accounts Payable	Inventory	Other Current Assets	Other Liab	Long Term Debt	Good Will	Short Term Investments
Total Assets		0.91	0.99	0.92	0.68	0.98	0.41	0.63	0.49	0.36	0.76	0.93	0.82	0.52	0.97	1.0	0.45	0.73	0.76	0.58	0.59	-0.46	0.67	0.91	0.92	0.74
Short Long Term Debt Total	0.91		0.86	0.89	0.92	0.85	0.03	0.74	0.67	0.13	0.55	0.95	0.78	0.65	0.92	0.91	0.17	0.54	0.84	0.74	0.54	-0.4	0.35	0.99	0.91	0.61
Total Stockholder Equity	0.99	0.86		0.93	0.62	0.98	0.45	0.62	0.48	0.36	0.78	0.91	0.8	0.51	0.96	0.99	0.45	0.75	0.74	0.55	0.59	-0.47	0.7	0.87	0.91	0.75
Property Plant And Equipment Net	0.92	0.89	0.93		0.74	0.87	0.19	0.85	0.75	0.02	0.65	0.92	0.7	0.77	0.95	0.92	0.1	0.64	0.88	0.68	0.42	-0.32	0.5	0.89	0.96	0.67
Net Debt	0.68	0.92	0.62	0.74		0.62	-0.37	0.73	0.74	-0.09	0.28	0.82	0.55	0.68	0.72	0.68	-0.13	0.33	0.77	0.72	0.37	-0.28	0.04	0.89	0.76	0.43
Retained Earnings	0.98	0.85	0.98	0.87	0.62		0.44	0.52	0.37	0.47	0.83	0.85	0.74	0.4	0.9	0.98	0.54	0.8	0.63	0.42	0.57	-0.49	0.73	0.85	0.82	0.81
Cash	0.41	0.03	0.45	0.19	-0.37	0.44		-0.14	-0.33	0.57	0.57	0.15	0.43	-0.23	0.3	0.4	0.76	0.49	-0.01	-0.13	0.32	-0.23	0.78	0.07	0.19	0.35
Non Current Assets Total	0.63	0.74	0.62	0.85	0.73	0.52	-0.14		0.98	-0.5	0.35	0.76	0.45	0.99	0.73	0.63	-0.4	0.31	0.89	0.75	0.08	0.0	0.09	0.71	0.83	0.43
Non Currrent Assets Other	0.49	0.67	0.48	0.75	0.74	0.37	-0.33	0.98		-0.61	0.17	0.67	0.35	0.99	0.62	0.49	-0.56	0.17	0.85	0.75	-0.02	0.08	-0.08	0.64	0.74	0.28
Other Assets	0.36	0.13	0.36	0.02	-0.09	0.47	0.57	-0.5	-0.61		0.41	0.13	0.37	-0.61	0.2	0.36	0.96	0.45	-0.23	-0.25	0.57	-0.52	0.63	0.18	0.03	0.3
Cash And Short Term Investments	0.76	0.55	0.78	0.65	0.28	0.83	0.57	0.35	0.17	0.41		0.58	0.49	0.24	0.66	0.76	0.54	0.73	0.38	0.11	0.37	-0.46	0.72	0.53	0.57	0.97
Net Receivables	0.93	0.95	0.91	0.92	0.82	0.85	0.15	0.76	0.67	0.13	0.58		0.83	0.67	0.97	0.93	0.2	0.5	0.92	0.83	0.64	-0.5	0.4	0.95	0.98	0.59
Common Stock Shares Outstanding	0.82	0.78	0.8	0.7	0.55	0.74	0.43	0.45	0.35	0.37	0.49	0.83		0.35	0.86	0.83	0.46	0.49	0.68	0.67	0.63	-0.4	0.58	0.83	0.81	0.42
Non Current Liabilities Total	0.52	0.65	0.51	0.77	0.68	0.4	-0.23	0.99	0.99	-0.61	0.24	0.67	0.35		0.64	0.52	-0.52	0.2	0.86	0.74	-0.01	0.07	-0.02	0.62	0.75	0.33
Other Stockholder Equity	0.97	0.92	0.96	0.95	0.72	0.9	0.3	0.73	0.62	0.2	0.66	0.97	0.86	0.64		0.97	0.29	0.6	0.87	0.74	0.59	-0.44	0.54	0.93	0.98	0.64
Total Liab	1.0	0.91	0.99	0.92	0.68	0.98	0.4	0.63	0.49	0.36	0.76	0.93	0.83	0.52	0.97		0.44	0.73	0.76	0.58	0.59	-0.46	0.66	0.92	0.92	0.73
Total Current Assets	0.45	0.17	0.45	0.1	-0.13	0.54	0.76	-0.4	-0.56	0.96	0.54	0.2	0.46	-0.52	0.29	0.44		0.48	-0.13	-0.18	0.58	-0.51	0.71	0.21	0.12	0.39
Common Stock	0.73	0.54	0.75	0.64	0.33	0.8	0.49	0.31	0.17	0.45	0.73	0.5	0.49	0.2	0.6	0.73	0.48		0.28	0.01	0.25	-0.23	0.88	0.53	0.51	0.71
Total Current Liabilities	0.76	0.84	0.74	0.88	0.77	0.63	-0.01	0.89	0.85	-0.23	0.38	0.92	0.68	0.86	0.87	0.76	-0.13	0.28		0.93	0.5	-0.37	0.15	0.83	0.94	0.42
Accounts Payable	0.58	0.74	0.55	0.68	0.72	0.42	-0.13	0.75	0.75	-0.25	0.11	0.83	0.67	0.74	0.74	0.58	-0.18	0.01	0.93		0.53	-0.35	-0.06	0.74	0.83	0.13
Inventory	0.59	0.54	0.59	0.42	0.37	0.57	0.32	0.08	-0.02	0.57	0.37	0.64	0.63	-0.01	0.59	0.59	0.58	0.25	0.5	0.53		-0.92	0.31	0.53	0.55	0.32
Other Current Assets	-0.46	-0.4	-0.47	-0.32	-0.28	-0.49	-0.23	0.0	0.08	-0.52	-0.46	-0.5	-0.4	0.07	-0.44	-0.46	-0.51	-0.23	-0.37	-0.35	-0.92		-0.24	-0.37	-0.4	-0.45
Other Liab	0.67	0.35	0.7	0.5	0.04	0.73	0.78	0.09	-0.08	0.63	0.72	0.4	0.58	-0.02	0.54	0.66	0.71	0.88	0.15	-0.06	0.31	-0.24		0.4	0.42	0.6
Long Term Debt	0.91	0.99	0.87	0.89	0.89	0.85	0.07	0.71	0.64	0.18	0.53	0.95	0.83	0.62	0.93	0.92	0.21	0.53	0.83	0.74	0.53	-0.37	0.4		0.92	0.58
Good Will	0.92	0.91	0.91	0.96	0.76	0.82	0.19	0.83	0.74	0.03	0.57	0.98	0.81	0.75	0.98	0.92	0.12	0.51	0.94	0.83	0.55	-0.4	0.42	0.92		0.58
Short Term Investments	0.74	0.61	0.75	0.67	0.43	0.81	0.35	0.43	0.28	0.3	0.97	0.59	0.42	0.33	0.64	0.73	0.39	0.71	0.42	0.13	0.32	-0.45	0.6	0.58	0.58

Click cells to compare fundamentals

Citizens Financial Account Relationship Matchups

Citizens Financial fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.5B	1.9B	2.1B	2.3B	3.0B	3.1B
Short Long Term Debt Total	85.1M	88.8M	74.0M	257.3M	322.0M	338.1M
Total Stockholder Equity	154.8M	194.3M	212.5M	200.1M	279.7M	293.6M
Property Plant And Equipment Net	15.9M	16.9M	17.0M	17.6M	32.5M	34.1M
Net Debt	52.3M	6.4M	(109.9M)	225.0M	265.1M	278.4M
Retained Earnings	110.8M	126.6M	146.0M	164.9M	173.0M	181.6M
Cash	32.8M	82.5M	183.9M	32.3M	52.8M	29.4M
Non Current Assets Total	282.0M	347.1M	464.7M	492.0M	2.9B	3.1B
Non Currrent Assets Other	(5.8M)	(9.9M)	(464.7M)	(12.9M)	2.4B	2.5B
Other Assets	906.3M	1.2B	1.1B	1.4B	6.4M	6.1M
Cash And Short Term Investments	273.5M	377.7M	596.3M	471.8M	470.4M	493.9M
Net Receivables	4.6M	6.0M	5.2M	7.3M	11.0M	11.6M
Common Stock Shares Outstanding	3.7M	3.9M	4.0M	4.0M	4.4M	4.1M
Liabilities And Stockholders Equity	1.5B	1.9B	2.1B	2.3B	3.0B	3.1B
Non Current Liabilities Total	85.1M	88.8M	74.0M	1.2M	2.7B	2.8B
Other Stockholder Equity	40.7M	60.7M	62.2M	63.9M	126.4M	132.8M
Total Liab	1.3B	1.7B	1.9B	2.1B	2.7B	2.8B
Total Current Assets	278.0M	383.7M	601.5M	479.1M	52.8M	66.8M
Common Stock	3.9M	4.4M	4.4M	4.4M	5.2M	3.4M
Accumulated Other Comprehensive Income	(629K)	2.6M	(155K)	(33.1M)	(24.9M)	(23.7M)
Total Current Liabilities	1.1M	1.0M	711K	1.2M	1.9B	2.0B
Accounts Payable	1.1M	1.0M	711K	1.2M	4.3M	4.5M
Inventory	(43.8M)	(90.3M)	(190.3M)	(40.1M)	26.7M	28.0M
Other Current Assets	43.8M	90.3M	190.3M	40.1M	68.5M	65.1M
Other Liab	12.4M	18.7M	20.5M	15.2M	17.4M	10.6M
Long Term Debt	85.1M	88.8M	74.0M	257.3M	322.0M	338.1M
Short Term Investments	240.7M	295.2M	412.4M	439.5M	417.6M	438.5M
Intangible Assets	1.3M	1.7M	1.6M	1.3M	3.7M	4.9M
Property Plant Equipment	17.1M	16.9M	17.0M	17.6M	20.3M	15.2M
Short Term Debt	56.4M	62.3M	47.3M	230.7M	213.7M	224.4M
Other Current Liab	(1.1M)	(1.0M)	(711K)	(1.2M)	(4.3M)	(4.1M)
Net Tangible Assets	130.8M	161.2M	179.5M	167.5M	192.6M	135.0M
Long Term Investments	241.4M	1.7B	1.8B	441.7M	419.5M	722.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Citizens Stock Analysis

When running Citizens Financial's price analysis, check to measure Citizens Financial's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Citizens Financial is operating at the current time. Most of Citizens Financial's value examination focuses on studying past and present price action to predict the probability of Citizens Financial's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Citizens Financial's price. Additionally, you may evaluate how the addition of Citizens Financial to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC